100 related articles for article (PubMed ID: 5751446)
1. [Urogenital cancer and aldolase].
Kurokawa K; Terao H; Fujimura N
Nihon Ishikai Zasshi; 1968 Sep; 60(5):416-20. PubMed ID: 5751446
[No Abstract] [Full Text] [Related]
2. [Isoenzymes of fructosephosphate aldolase in patients with tumors of the urogenital system. XII. Isoenzymes of fructosephosphate aldolase].
Dikow AL; Donowski L
Z Klin Chem Klin Biochem; 1970 Mar; 8(2):124-6. PubMed ID: 5421230
[No Abstract] [Full Text] [Related]
3. [Indicators of alkaline phosphatase and peroxidase in the leukocytes of the peripheral blood in patients with cancer of the urogenital system].
Matskiv AS; Zabolotskiĭ AT; Sultan NN
Vrach Delo; 1973 Nov; 11():67-70. PubMed ID: 4132245
[No Abstract] [Full Text] [Related]
4. [Immunochemical analysis of prostatic acid phosphatase. 3. Evaluation of patients with prostatic cancers and cancer of other organs and a comparison with conventional method].
Sakai S; Kato N; Shimazu R; Doi T; Shimizu Y; Kawada Y; Nishiura T; Sawada H
Nihon Hinyokika Gakkai Zasshi; 1982 May; 73(5):609-18. PubMed ID: 6184513
[No Abstract] [Full Text] [Related]
5. [Value of serum aldolase in the early diagnosis of prostatic carcinoma].
Maganto Pavón E; Daimiel Fernández ER; Navajo Lindo JA; Isorna S; Martínez Piñeiro JA
Rev Clin Esp; 1979 Feb; 152(3):227-30. PubMed ID: 441476
[No Abstract] [Full Text] [Related]
6. Arginase in human urogenital tumors.
Yamanaka H; Mayuzumi T; Matsuoka M; Shimazaki J; Shida K
Gan; 1972 Dec; 63(6):693-700. PubMed ID: 4119243
[No Abstract] [Full Text] [Related]
7. [Urological studies on aldolase. 3. With special regard to aldolase isozymes in human tissues].
Terao N
Nihon Hinyokika Gakkai Zasshi; 1968 Oct; 59(10):865-72. PubMed ID: 5751770
[No Abstract] [Full Text] [Related]
8. Isoenzyme patterns of prostatic acid phosphatase in serum, urine, and homogenates from men and women.
Nordström L; Ekman P; Eneroth P; Lewenhaupt A
Scand J Clin Lab Invest Suppl; 1985; 179():89-100. PubMed ID: 2417307
[No Abstract] [Full Text] [Related]
9. [Serum aldolase in prostatic cancer].
Maganto-Pavón E; Isorna S; Navajo-Galindo JA; Daimiel-Fernández ER; Martínez-Piñeiro JA
Actas Urol Esp; 1979; 3(4):227-30. PubMed ID: 484308
[No Abstract] [Full Text] [Related]
10. Aldolase activity in benign prostatic hypertrophy and adenocarcinomatous prostate.
Verlooy J; van Sande M; Van Camp K
Acta Urol Belg; 1980 Jan; 48(1):65-7. PubMed ID: 6159782
[No Abstract] [Full Text] [Related]
11. Histological examination of the aldolase monomer composition of cells from human kidney and hypernephroid carcinoma.
Pfleiderer G; Thöner M; Wachsmuth ED
Beitr Pathol; 1975 Dec; 156(3):266-79. PubMed ID: 766744
[TBL] [Abstract][Full Text] [Related]
12. Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implication for attenuated p53 response to apoptotic stresses.
Lee MG; Huh JS; Chung SK; Lee JH; Byun DS; Ryu BK; Kang MJ; Chae KS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
Oncogene; 2006 Sep; 25(42):5807-22. PubMed ID: 16909101
[TBL] [Abstract][Full Text] [Related]
13. Staining of bladder tumor cell dehydrogenase.
Kawamura N
Tokai J Exp Clin Med; 1980 Oct; 5(4):421-33. PubMed ID: 6166091
[TBL] [Abstract][Full Text] [Related]
14. [On serum aldolase activity in carcinomas of the prostate].
Frugoni A; Chianta A
Minerva Urol; 1968; 20(1):1-4. PubMed ID: 5738630
[No Abstract] [Full Text] [Related]
15. Fetal-type isoenzymes in hepatic and nonhepatic rat tumors.
Farron F; Hsu HH; Knox WE
Cancer Res; 1972 Feb; 32(2):302-8. PubMed ID: 4333495
[No Abstract] [Full Text] [Related]
16. Studies on glycolytic enzymes in relation to cancer. 3. Clinical significance of serum phosphohexose isomerase and aldolase in cancer of the prostate. A comparative study with serum acid phosphatase and serum alkaline phosphatase.
Damle SR; Talavdekar RV; Panse TB
Indian J Cancer; 1971 Sep; 8(3):176-84. PubMed ID: 5141722
[No Abstract] [Full Text] [Related]
17. [A study on aldolase activity and isozyme pattern of the bladder tumor (author's transl)].
Tanaka R
Nihon Hinyokika Gakkai Zasshi; 1974 Jul; 65(7):437-53. PubMed ID: 4141743
[No Abstract] [Full Text] [Related]
18. Urine and blood serum muramidase (lysozyme) in patients with urogenital tumors.
Kovanyi G; Letnansky K
Eur J Cancer (1965); 1971 Feb; 7(1):25-31. PubMed ID: 4102704
[No Abstract] [Full Text] [Related]
19. Serum ribonuclease in urologic cancer. Relation to host immunocompetence.
Catalona WJ; Chretien PB; Matthews WJ; Tarpley JL
Urology; 1973 Nov; 2(5):577-81. PubMed ID: 4797457
[No Abstract] [Full Text] [Related]
20. Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo.
Nagasawa J; Mizokami A; Koshida K; Yoshida S; Naito K; Namiki M
Int J Urol; 2006 May; 13(5):587-92. PubMed ID: 16771730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
